Evidence-based Treatment Options in Cannabis Dependency

被引:15
|
作者
Walther, Lisa [1 ]
Gantner, Andreas [2 ]
Heinz, Andreas [1 ,3 ]
Majic, Tomislav [3 ]
机构
[1] Charite, Dept Psychiat & Psychotherapy, Campus Mitte, Berlin, Germany
[2] Therapieladen eV, Berlin, Germany
[3] Charite, St Hedwig Hosp, Dept Psychiat & Psychotherapy, Charite Campus Mitte, Berlin, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2016年 / 113卷 / 39期
关键词
RANDOMIZED CONTROLLED-TRIAL; MULTIDIMENSIONAL FAMILY-THERAPY; COGNITIVE-BEHAVIORAL THERAPY; PLACEBO-CONTROLLED TRIAL; STUDENT MARIJUANA USE; DOUBLE-BLIND; USE DISORDERS; TREATMENT PROGRAM; MOTIVATIONAL ENHANCEMENT; BRIEF INTERVENTION;
D O I
10.3238/arztebl.2016.0653
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Now that the consumption of natural and synthetic cannabinoids is becoming more widespread, the specific treatment of cannabis-related disturbances is an increasingly important matter. There are many therapeutic options, and it is not always clear which ones are evidence-based and appropriate for use in a given clinical situation. Methods: This review is based on reports of pertinent randomized and controlled trials (RCTs) that were retrieved by a selective search in the PubMed and Cochrane databases. Results: Cognitive behavior therapy (CBT) combined with other techniques has been found to have a moderate to large effect (Cohen's d = 0.53-0.9) on the amount of cannabis consumed as well as on the level of psychosocial functioning or the dependence syndrome. Systemic multidimensional family therapy (MDFT) has been found beneficial for younger adolescents who consume large amounts of cannabis and have psychiatric comorbidities. Short-term interventions with motivational talk therapy have been found effective for patients with or without an initial desire to achieve cannabis abstinence. All of these psychotherapeutic interventions are effective at evidence level Ia. The administration of gabapentin had a weak effect (d = 0.26) on the quantity consumed and on abstinence (evidence level Ib). Withdrawal symptoms can be alleviated with cannabinoid-receptor antagonists (d = 0.223 and 0.481) (evidence level Ib). On the other hand, there is evidence that serotonergic antidepressants can worsen withdrawal manifestations and increase the likelihood of relapse. Conclusion: Psychotherapeutic techniques remain the foundation of treatment for cannabis dependence. No drug has yet been approved for the treatment of cannabis dependence because of the lack of scientific evidence. The rates of abstinence that are currently achieved, even with psychotherapy, are still only moderate. Further clinical studies are needed for the evaluation of combinations of various treatments that can meet the needs of individual patients.
引用
收藏
页码:653 / +
页数:9
相关论文
共 50 条
  • [31] Non-Pharmacological Treatment of Depressive Disorders: A Review of Evidence-Based Treatment Options
    Dirmaier, J.
    Steinmann, M.
    Krattenmacher, T.
    Watzke, B.
    Barghaan, D.
    Koch, U.
    Schulz, H.
    REVIEWS ON RECENT CLINICAL TRIALS, 2012, 7 (02) : 141 - 149
  • [32] RHEUMATOID ARTHRITIS Evidence-based rather than habit-based treatment options
    Yazici, Yusuf
    NATURE REVIEWS RHEUMATOLOGY, 2012, 8 (07) : 374 - 376
  • [33] Biologic treatment options for pityriasis rubra pilaris: An evidence-based systematic review
    Sood, Siddhartha
    Akuffo-Addo, Edgar
    Yeung, Jensen
    Mufti, Asjandyar
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (06) : 1306 - 1308
  • [34] Menopausal vasomotor symptoms - A review of causes, effects and evidence-based treatment options
    Bachmann, GA
    JOURNAL OF REPRODUCTIVE MEDICINE, 2005, 50 (03) : 155 - 165
  • [35] Why We Should Consider Evidence-Based Treatment Options for Truncal Acne
    Linda Stein Gold
    Thomas Dirschka
    Dermatology and Therapy, 2021, 11 : 661 - 664
  • [36] Manual therapy for headache patients: overview of evidence-based referral and treatment options
    De Hertogh, W
    Vaes, P
    Oostendorp, R
    CEPHALALGIA, 2005, 25 (08) : 655 - 656
  • [37] Evidence-based options for treatment-resistant adult bipolar disorder patients
    Poon, Shi Hui
    Sim, Kang
    Sum, Min Yi
    Kuswanto, Carissa Nadia
    Baldessarini, Ross J.
    BIPOLAR DISORDERS, 2012, 14 (06) : 573 - 584
  • [38] Colorectal peritoneal metastases: pathogenesis, diagnosis and treatment options - an evidence-based update
    Narasimhan, Vignesh
    Ooi, Geraldine
    Michael, Michael
    Ramsay, Robert
    Lynch, Craig
    Heriot, Alexander
    ANZ JOURNAL OF SURGERY, 2020, 90 (09) : 1592 - 1597
  • [39] Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach
    Sarma, Phulen
    Prajapat, Manisha
    Avti, Pramod
    Kaur, Hardeep
    Kumar, Subodh
    Medhi, Bikash
    INDIAN JOURNAL OF PHARMACOLOGY, 2020, 52 (01) : 1 - 5
  • [40] Current and emerging evidence-based treatment options in chronic migraine: a narrative review
    Agostoni, Elio Clemente
    Barbanti, Piero
    Calabresi, Paolo
    Colombo, Bruno
    Cortelli, Pietro
    Frediani, Fabio
    Geppetti, Pietrangelo
    Grazzi, Licia
    Leone, Massimo
    Martelletti, Paolo
    Pini, Luigi Alberto
    Prudenzano, Maria Pia
    Sarchielli, Paola
    Tedeschi, Gioacchino
    Russo, Antonio
    JOURNAL OF HEADACHE AND PAIN, 2019, 20 (01):